Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers

被引：0
|
作者：
E Peters
J Arend
R Tiessen
A Van Elsas
R Masereeuw
P Pickkers
机构：
[1] Radboudumc,
[2] AM-Pharma,undefined
[3] PRA Health Sciences,undefined
来源：
Critical Care | / 19卷 / Suppl 1期
关键词：
Healthy Volunteer; Acute Kidney Injury; Clinical Trial Register; Stable Serum; Intestinal Alkaline Phosphatase;
D O I：
10.1186/cc14206
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Safety, Tolerability, and Pharmacokinetics of High-Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers
    Dolton, Michael J.
    Chesterman, Aaron
    Moein, Anita
    Sink, Kaycee M.
    Waitz, Ariel
    Blondeau, Kathleen
    Kerchner, Geoffrey A.
    Hu, Nan
    Brooks, Logan
    Roden, Amanda
    Deshmukh, Ajay
    Peng, Kun
    Smith, Jill
    Ostrowitzki, Susanne
    Quartino, Angelica
    Carrasco-Triguero, Montserrat
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1337 - 1348
  • [2] Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers
    Miceli, JJ
    Wilner, KD
    Swan, SK
    Tensfeldt, TG
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (06): : 620 - 630
  • [3] Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers
    Tummala, Raj
    Rouse, Tomas
    Berglind, Anna
    Santiago, Linda
    [J]. LUPUS SCIENCE & MEDICINE, 2018, 5 (01):
  • [4] SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUBCUTANEOUS AND INTRAVENOUS ANIFROLUMAB IN HEALTHY VOLUNTEERS
    Tummala, R.
    Rouse, T.
    Berglind, A.
    Santiago, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 870 - 870
  • [5] Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intravenous Anifrolumab in Healthy Volunteers
    Tummala, Raj
    Rouse, Tomas
    Berglind, Anna
    Santiago, Linda
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
    Peterschmitt, M. Judith
    Crawford, Nigel P. S.
    Gaemers, Sebastiaan J. M.
    Ji, Allena J.
    Sharma, Jyoti
    Pham, Theresa T.
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (01): : 86 - 98
  • [7] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Losmapimod in Healthy Japanese Volunteers
    Ino, Hiroko
    Takahashi, Naoki
    Terao, Takumi
    Igarashi, Harue
    Sarai, Nobuaki
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (04): : 262 - 269
  • [8] Safety, Tolerability, and Pharmacokinetics of Intravenous Nemonoxacin in Healthy Chinese Volunteers
    Cao, Guo-ying
    Zhang, Jing
    Zhang, Ying-yuan
    Guo, Bei-ning
    Yu, Ji-cheng
    Wu, Xiao-jie
    Chen, Yuan-cheng
    Wu, Ju-fang
    Shi, Yao-guo
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) : 6116 - 6121
  • [9] A First-in-Human Safety, Tolerability, and Pharmacokinetics Study of Benapenem in Healthy Chinese Volunteers
    Zhao, Cai-Yun
    Lv, Yuan
    Zhu, Yan
    Wei, Min-Ji
    Liu, Meng-Ying
    Ji, Xi-Wei
    Kang, Zi-Sheng
    Xia, Ya-Hong
    Tian, Ji-Hong
    Ma, Yan
    Liu, Yan
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [10] Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects
    Xu, Junyu
    Sun, Peihong
    Zhao, Xia
    Meng, Lei
    Wang, Xiaorui
    Qin, Xiaoyan
    Zhou, Ying
    Zhou, Mingdong
    Cui, Yimin
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (04) : 419 - 428
12345